David W. Hillman

Also affiliated with Mayo Clinic in Arizona

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)”.

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

European Journal of Cancer(2021)10.1016/j.ejca.2021.01.053

N/A

0.685DataRank · unranked

28 citations

Eileen Holmes, Christian Jackisch, Evandro de Azambuja, Frances Boyle, David W. Hillman +37 more

Long-term outcomes of patients with node-negative (N0), triple-negative breast cancer (TNBC) who did not receive adjuvant chemotherapy according to stromal TILs (sTILs).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.548

N/A

0DataRank · unranked

0 citations

Jodi M. Carter, David W. Hillman, Kathleen Tenner, David M. Zahrieh, Minetta C. Liu +7 more

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0099

N/A

0DataRank · unranked

17 citations

Krishna R. Kalari, Sisi Qin, Scott M. Dehm, Vipul Bhargava, Michael Gormley +12 more

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

0DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

Nature Communications(2023)10.1038/s41467-023-42635-2

N/A

0DataRank · unranked

17 citations

Aranzazu Fernández-Martínez, David Venet, Françoise Rothé, Katherine A. Hoadley, Joel S. Parker +17 more

Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0803

N/A

0DataRank · unranked

10 citations

Olivia Bobek, Irenaeus C.C. Chan, Brian C. Miller, David W. Hillman, Glenn Heller +8 more

Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.510

N/A

0DataRank · unranked

2 citations

Jodi M. Carter, Yaohua Ma, Douglas Hinerfeld, Heather Ann Brauer, Sarah Warren +15 more

Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00629-3

N/A

0DataRank · unranked

1 citations

Jodi M. Carter, David M. Zahrieh, Jason P. Sinnwell, Roberto Salgado, Vera J. Suman +10 more